CASI Pharmaceuticals launches first product in China

In brief: CASI Pharmaceuticals launches first product in China

CASI Pharmaceuticals is launching its first commercial product in China via partner Ligand Pharmaceuticals. The company will launch melphalan hydrochloride for injection (Evomela), which uses...
Neuraxpharm launch first products in UK

Neuraxpharm launch first products in UK

Neuraxpharm Group, a European pharmaceutical company focussed on central nervous system (CNS) disorders, has launched its first products in the UK. The company will be...
UK’s first convergent science centre officially launches

UK’s first convergent science centre officially launches

A £13 million Cancer Research UK Convergence Science Centre has officially opened at The Institute of Cancer Research and Imperial College London in a...
Asthma guidance to publish in the UK

Asthma guidance to publish in the UK

A future UK-wide guidance for the diagnosis and management of asthma in patients will be produced by the National Institute for Health and Care...
FDA approves new drug for treatment-resistant tuberculosis

J&J launches research consortium to help end tuberculosis

Johnson & Johnson has launched an international research consortium to discover and develop new tuberculosis (TB) antibiotics. Working in collaboration with eight European academic and...